More than 1.2 million medical device adverse event reports, constituting nearly one-third of all submissions, were not promptly reported to the U.S. Food and Drug Administration (FDA) as required, according to a recent report. Researchers assessed the timeliness of adverse event reporting by medical device manufacturers, highlighting the significant delays and the potential impact on postmarket surveillance. The results indicated that a considerable number of reports were submitted late, with stricter compliance measures and greater transparency suggested as potential improvements.